KLAS Contact
Contact KLAS
Contact KLAS
2025 BEST IN KLAS
Preferences
Related Series
2022
Related Segments
Asia/Oceania EHR 2025
A Look at Vendor Performance & Market Share amid Growing Adoption & Customer Expectations
Author
Steve VanWagenen
Author
Jonathan Christensen
Author
Spencer Corbett
Buying energy and digital maturity are growing among healthcare organizations in Asia and Oceania, with many either adopting their first EHR or enhancing interoperability to keep pace with local initiatives. As EHR maturity deepens, organizations increasingly expect more from their vendors in terms of value and up-to-date technology. A follow-up to 2022 data, this report examines market energy in Asia and Oceania as well as customer satisfaction with key vendors. Notably, insights on Asia are broken out for the first time into two subregions: East Asia and South/Southeast Asia. (For a deeper dive into EHR dynamics in India, see the recent India EMR 2025 report.)
If you don't have a login, getting started is easy.
Key Findings:
- IQVIA Gaining Momentum in Southeast Asia; Epic Expands in Australia via Large Regional Initiative
- South/Southeast Asia: InterSystems Drives Highest Customer Satisfaction as Organizations Focus on Value
- East Asia: Winning Health, iMEDWAY & ezCaretech* Are Good Country-Specific Options
- In Oceania, High Expectations Drive General Dissatisfaction; InterSystems Leads in Satisfaction, While Oracle Health Falls to 10-Year Low
*Limited data
Writer
Carlisa Cramer
Designer
Nikki Christensen
Project Manager
Sydney Toomer
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2025 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.